MDHHS Opioid Start Talking Form Now Available to Hospitals, Healthcare Providers
Posted on April 25, 2018
In response to legislation aimed at combatting the opioid epidemic, the Michigan Department of Health and Human Services (MDHHS) has released a new document, the Opioid Start Talking Form. As required by Public Act (PA) 246 of 2017, the form is designed to satisfy new patient education and parental consent regulations regarding opioid prescriptions beginning June 1, 2018. Healthcare providers can download the Word template version of the form or access it under the Prescribers tab on the MDHHS website.
To streamline clinical workflow and avoid confusion, state healthcare officials opted to create one document to fulfill two major requirements within PA 246, as outlined below.
- Beginning June 1, 2018, a prescriber or licensed health professional must provide education on the dangers, disposal and diversion consequences of opioids before prescribing an opioid to a patient. The Start Talking Consent form mentioned above fulfills this requirement.
- Beginning June 1, 2018, parental consent and signature on the Start Talking Consent Form is required before minors receive their first prescription of a controlled substance containing an opioid. Prior to obtaining consent, the prescriber must discuss the potential risk of addiction and overdose with both the minor and the parent/guardian.
Additional information about the latest legislative efforts regarding opioids and more can be found on the Opioid and Prescription Drug Epidemic section of the MHA website.
On a separate but related issue, the Prescription Drug and Opioid Abuse Commission on April 20 released its prescribing recommendations for surgeons, emergency departments and dentists in the treatment of acute pain. The 17-member commission was created by an executive order of Gov. Rick Snyder in June 2016 and is made up of health professionals, law enforcement officers, substance abuse treatment providers, government officials and citizens. The body serves in an advisory capacity to the governor and the Michigan Department of Licensing and Regulatory Affairs.
Members with questions about advocacy efforts related to opioids should contact Paige Fults at the MHA. For more information about the MHA’s efforts regarding pain management, contact the MHA Keystone Center.
Posted in: Issues in Healthcare, Member News, Top Issues - Healthcare